psilocybin Archives

StaffSeptember 10, 2020

Havn Life Sciences announced that, on August 31, 2020, its wholly-owned subsidiary, HAVN Research Inc., was granted a Section 56 exemption by Health Canada, meaning it now has the ability to possess certain amounts of pure psilocybin for scientific purposes, specifically for the research and development of quality control methods. Havn Life said it plans […]

Debra BorchardtSeptember 1, 2020

The UK-based mental health company known for its psychedelic treatments, Compass Pathways has filed to go public this week. The company said it plans to list its American depositary shares on the Nasdaq under the ticker “CMPS”. The company reported total net losses of $13.2 million, $19.6 million and $24.8 million, respectively, for the fiscal […]

Debra BorchardtJuly 7, 2020

Despite the continuing opportunities for the cannabis industry, many companies have decided that they don’t want to miss out on the emergence of the mushroom industry. The latest entry to the psilocybin race is CannaGlobal Wellness. This company is a combination of CannaGlobal, Sansero Life Sciences, and Rise Wellness. The new company said it will focus […]

StaffJuly 2, 2020

A Florida based biotechnology company specializing in the clinical development of psychedelics and analogs is the latest to jump into the quickly growing plant-based medicine field. Psilera Bioscience was launched this month by co-founders Drs. Jackie Salm and Chris Witowski who have 20+ years of combined experience in natural product drug discovery, novel formulations, and […]

Debra BorchardtJuly 2, 2020

The star of the quickly growing plant-based medicine field is currently the mushroom – specifically, the psilocybin mushroom. It’s being touted as a treatment for drug-resistant depression and addiction. Clinics are being discussed as places to administer doses of psilocybin, but it seems the non-medical use has been brushed under the rug. A new study […]

Debra BorchardtApril 29, 2020

Specialty life science company Revive Therapeutics Ltd. (CSE: RVV) has said that it will investigate novel oral dosage forms of psilocybin, such as oral dissolvable thin films or tablets, based on its wholly-owned patent-pending psilocybin formulations and its exclusive licensed drug delivery technology from the Wisconsin Alumni Research Foundation. “We are expanding our psilocybin-based pharmaceutical […]

Debra BorchardtApril 14, 2020

Biotech holding company Orthogonal Thinker, Inc. said that it has completed filing a provisional application for the Company’s flagship natural product, Psilly. The provisional application is a legal document filed in the United States Patent and Trademark Office (USPTO), that establishes an early filing date. It does not mature into an issued patent unless the applicant files a regular non-provisional patent […]

Debra BorchardtApril 10, 2020

Mushroom company Champignon Brands Inc. (OTC:SHRMF) has entered into a definitive agreement to acquire Canadian ketamine clinic operator AltMed Capital Corp. Champignon said that AltMed has a suite of assets that will hasten Champignon’s anticipated rollout of new clinics to be opened across the United States and Canada. Five new clinics in key markets, including […]

Debra BorchardtMarch 30, 2020

Medicinal mushroom company Champignon Brands Inc. (CSE: SHRM) has entered into a definitive agreement to acquire Tassili Life Sciences Corp. in an all-stock deal. Tassili will receive 16 million shares, which is roughly C$7.3 million. The acquisition will expand Champignon’s preclinical trial pipeline, as well as its aggregation of broad intellectual property related to the […]

StaffJanuary 21, 2020

Just as the psilocybin mushroom market begins to heat up, one enterprising entrepreneur has quickly snapped up the trademark for the word “Psilocybin.” Marijuana Moment picked up on the founder’s notice on LinkedIn that the word had been trademarked. That post has since disappeared and while there is no mention of the trademark happening on […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: psilocybin

Health Canada Grants HAVN Life Sciences Permission For Psilocybin Research

Psychedelic Company Compass Pathways Files To Go Public

Another Cannabis Company Jumps Into Psilocybin

New Psilocybin Company Enters The Market

There’s A Case For Non-Medical Psilocybin

Revive Therapeutics Researching Oral Dosage Of Psilocybin

Orthogonal Thinker Takes Steps Towards Patenting Psilocybin Product

Mushroom Company Champignon Acquires AltMed CapitalCorp.

Medical Mushroom Company Champignon Brands To Acquire Tassili Life Sciences

Chocolate Brand Trademarks The Word Psilocybin

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox